This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read MoreTargeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read MoreNames on the move ahead of the open. Source link
Read MorePharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including
Read MorePresident Emmanuel Macron will kick off the annual 'Choose France' event aimed at wooing big overseas businesses and investors on
Read MoreAmgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments. Source link
Read MoreThe tech-heavy index closed at its first record high in more than two years on Thursday. Source link
Read MoreAs the bull market slows, these cheap stocks could emerge as big winners. Source link
Read MoreAnti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming. Source link
Read MoreOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600
Read More